Les poisons des topo-isomérases I-Reference-Cited by-同舟云学术

Les poisons des topo-isomérases I

Published:2007-11 Issue:11 Volume:9 Page:758-765
ISSN:1292-3818
Container-title:Oncologie
language:fr
Short-container-title:Oncologie

Author:

Goldwasser F.

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10269-007-0769-z.pdf

Reference57 articles.

1. Abigerges D, Armand JP, Chabot GG, et al. (1994) Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J Natl Cancer Inst 86(6): 446–9

2. Abigerges D, Chabot GG, Armand JP, et al. (1995) Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients. J Clin Oncol 13(1): 210–21

3. Alexandre J, Gross-Goupil M, Nguyen ML, et al. (2003) Evaluation of the nutritional and inflammatory status of cancer patients to assess the risk of severe hematologic toxicity of antineoplastic regimens. Ann Oncol 14(1): 36–41

4. Alexandre J, Tigaud JM, Gross-Goupil M, et al. (2002) Combination of topotecan and oxaliplatin in inoperable hepatocellular cancer patients. Am J Clin Oncol 25(2): 198–203

5. Ando Y, Saka H, Ando M, et al. (2000) Polymorphisms of UDP-glucuronosyl-transferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60(24): 6921–6

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traitement du cancer colorectal métastatique : une illustration de l’évolution des concepts fondateurs de la cancérologie;La Presse Médicale;2012-01